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Abstract
Background
Drug overdose deaths have become an escalating epidemic in the U.S. and surpassed
motor vehicle collisions as the leading cause of accidental death. To combat opioid overdose,
naloxone distribution to the public has been initiated in some states as a harm reduction strategy.
Naloxone has been used for many years among hospital professionals as a life-saving antidote to
reverse the respiratory depression effects of opioids, and the FDA has approved take-home
naloxone devices for layperson use. Though legislation has been introduced in many states, such
as Tennessee, to allow provider prescription of naloxone to laypersons, minimal data have been
recorded to determine if NPs are willing to prescribe naloxone to patients.
Purpose
The purpose of this project was to explore how knowledge, attitudes, and subjective
norms influence intentions to prescribe naloxone to laypersons among Tennessee nurse
practitioners (NPs) following implementation of state naloxone distribution laws.
Methods
Using the Theory of Reasoned Action as the theoretical framework, NPs’ knowledge,
attitudes, subjective norms, and intentions to prescribe naloxone were assessed using web-based
surveys. While 6,196 Tennessee NPs were emailed the survey, purposive sampling included only
NPs practicing in adult primary care clinics, family practice clinics, pain management clinics,
and emergency departments in the final sample. Descriptive and Pearson’s Chi-Square statistics
were used to analyze survey responses and correlations were established using SPSS software.
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Results
Of 343 NPs included in the final sample, only 16.6% intended to prescribe naloxone to
laypersons, which significantly correlated with NPs’ knowledge, attitudes, and subjective norms.
No significant correlation was found between geographical location and intention to prescribe.
Intention to prescribe percentages increased dramatically from 16.6% to 58% when NPs were
asked if they would prescribe naloxone to laypersons with prescribing protocols in place.
Discussion
This study’s results confirmed the literature’s suggestion that healthcare providers are
relatively unaware of the evidence surrounding naloxone distribution safety and efficacy.
Negative attitudes toward naloxone distribution and uncertainty over legal protection contributed
to unwillingness to prescribe. Better education, training, legal clarification, and prescribing
protocols should be given to NPs and other healthcare providers to increase involvement with
naloxone prescription for laypersons.
Keywords: naloxone, naloxone distribution, opioid overdose, opioid overdose deaths,
provider attitudes, nurse practitioner attitudes, harm reduction strategy, public health, theoretical
framework, correlational statistics; Chi-Square
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Public Access to Naloxone: Intention to Prescribe Among Tennessee Nurse Practitioners
Across the globe, drug overdose has become a devastating epidemic and surpassed motor
vehicle collisions as the leading cause of adult accidental death in the United States (U.S.)
(Centers for Disease Control and Prevention [CDC], 2015a). Of the annual U.S. death toll,
pharmaceuticals contributed to approximately 22,767 overdose deaths with 71.3% related to
opioid pain medications (CDC, 2015a). For many years, the life-saving opioid antidote, known
as naloxone, has been used among healthcare professionals in hospitals to quickly and effectively
reverse the respiratory depressive effects of opioids (Wermeling, 2015). Public health efforts and
current legislation have focused on distributing naloxone to non-medically trained laypersons
and training these laypersons to administer naloxone to victims in opioid overdose events. This
Doctor of Nursing Practice (DNP) project explored the psychosocial factors influencing nurse
practitioners’ (NPs’) intentions to prescribe naloxone to laypersons as an opioid overdose
prevention strategy.
Background
Opioid Overdose Epidemic and Naloxone Distribution
The number of opioid overdose deaths has continued to rise each year causing a public
health crisis as well as almost $72 billion in annual medical costs (U.S. Department of Health
and Human Services [HHS], 2013). While intravenous (IV) heroin caused many deaths,
prescription opioid pain medications, such as oxycodone, hydrocodone, and morphine, have
killed more people than cocaine and heroin combined (National Institute on Drug Abuse, 2014).
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This complex problem has been directly associated with inappropriate prescription of opioid
medications by healthcare providers, who wrote nearly 259 million opioid prescriptions in one
year (CDC, 2016). While some patients have truly required prescription opioids for chronic pain
management, other individuals have solicited providers to prescribe opioids for personal
illegitimate use, selling on the street, or supplying to friends and family.
To reduce the high number of opioid overdose deaths that occurred while victims waited
for help to arrive, naloxone distribution was introduced as a harm reduction strategy, equipping
individuals most likely to encounter opioid overdose events with the life-saving antidote (Davis,
2015). Efforts to increase public access to naloxone supplement ongoing opioid overdose
prevention efforts, such as prescription drug monitoring databases, prescription drug disposal
programs, substance abuse rehabilitation, and stricter opioid prescribing guidelines for healthcare
providers (Kim, Irwin, & Khoshnood, 2009). Forty-three states have implemented legislation
allowing provider prescription of take-home naloxone (THN) to non-medically trained
laypersons, which include patients and their family members or friends (Davis, 2015).
Thirty-five of these 43 states also passed Good Samaritan laws to protect laypersons and
naloxone prescribers from legal repercussions when laypersons administer naloxone to opioid
overdose victims in pre-hospital emergencies (Davis, 2015). Not only has public naloxone
distribution become an overdose prevention strategy in the U.S., but also the World Health
Organization (2014) endorsed its global significance of successfully preventing overdose deaths
in countries around the world, such as England, Australia, Canada, and Scotland.
Many of the U.S. naloxone laws were introduced in response to the 2014 U.S. Food and
Drug Administration (FDA, 2014) approval of Evzio™, which was the first THN auto-injector
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device intended for layperson administration in pre-hospital settings. More recently in November
2015, the FDA (2015) announced its approval of a naloxone intranasal (IN) spray, which
expanded public access to THN by approving an alternative delivery route. Though
community-based overdose education programs (OEPs) have been providing generic THN kits
and overdose response training to opioid abusers since 1996, the recent increase in state
naloxone laws and growing political support for public naloxone access have dramatically
expanded THN distribution to diverse settings and patient populations (Wheeler, Jones, Gilbert,
& Davidson, 2015). As of 2014, THN was used to reverse approximately 26,463 opioid
overdoses among individuals receiving overdose response training at community OEPs across
the U.S., and research has supported that laypersons who receive appropriate training can
accurately recognize signs of overdose and safely administer naloxone (Wheeler et al., 2015).
Evidence suggests that improving public access to naloxone is not only effective and practical,
but it is also cost-effective (Coffin & Sullivan, 2013).
Healthcare Provider Involvement with Naloxone Distribution
Despite increased legislation and political support for naloxone distribution across the
U.S., poor provider involvement with naloxone distribution efforts has been recognized as a
significant barrier to realizing the widespread impact of THN on opioid overdose (Beletsky et al.,
2007; Burris et al., 2009; Davis, 2015; Kim et al., 2009). In a study by Beletsky et al. (2007),
only 23% of surveyed physicians reported knowledge of naloxone prescription to laypersons as
an overdose prevention strategy. Fifty-four percent of the same sample stated that they would not
prescribe THN, which authors attributed to lack of awareness regarding naloxone laws, negative
attitudes toward drug users, and malpractice liability concerns (Beletsky et al., 2007). If
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healthcare providers remain unwilling to prescribe naloxone to laypersons, this harm reduction
strategy’s true effectiveness on decreasing overdose deaths will be impossible to realize.
Tennessee’s Opioid Crisis and Naloxone Distribution Status
In 2014, 1,263 Tennesseans died of opioid overdose, a death toll that has continued to
rise each year despite the Tennessee Department of Health’s (TDH’s, 2015b) efforts to decrease
substance abuse and misuse. Because Tennessee was ranked as the highest prescribing state for
opioid analgesics with 143 prescriptions written per 100 persons, it has become crucial to glean
more information about Tennessee provider prescribing practices (CDC, 2016). As of March 19,
2016, 295 chronic pain management clinics were registered with TDH (2016), which alludes to
the excessive number of opioids in circulation. To counteract this problem, the TDH (2014)
introduced chronic pain management guidelines that describe new opioid prescribing protocols,
the controlled substance monitoring database, prescription drug disposal, and naloxone
distribution to laypersons.
In April 2014, Tennessee policymakers passed the Naloxone Rescue Act, which allows
healthcare providers to prescribe naloxone to laypersons and protects all involved parties against
civil prosecution if acting in good faith (Naloxone Rescue Act, Tenn. Code Ann. § 63-1-152
(2014)). The Addiction Treatment Act added necessary adjustments to the Good Samaritan law
to allow better protection from criminal prosecution for laypersons who call emergency services
after administering naloxone in an overdose event (Addiction Treatment Act of 2015, Tenn.
Code Ann. § 63-1-1 et seq. (2015)). Since the conception of this DNP project, legislation and
implementation of THN distribution in Tennessee and other U.S. states have evolved at a fast
pace. On September 23, 2015, CVS Pharmacy (2015) announced that its stores in 12 states,
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which includes Tennessee, will sell THN to patients without individual prescriptions. Following
CVS Pharmacy’s example, Walgreens Pharmacy (2016) made a February 9, 2016,
announcement that its stores will also begin dispensing THN without prescriptions in 35 states
and Washington, D. C. This type of THN distribution would be in line with Tennessee’s
Naloxone Rescue Act through its use of a standing order agreement between a physician and
CVS Pharmacy (2015). Little to no data have been published to evaluate if naloxone laws have
reduced the number of opioid overdose deaths in Tennessee.
Purpose of Project
More data have been needed to discover whether or not NPs are aware of naloxone laws
and if they believe naloxone distribution is a good strategy for opioid overdose prevention.
Though Tennessee’s Naloxone Rescue Act has been in effect for almost two years, no data have
been found to determine if NPs intend to prescribe THN to patients and their friends or family
members. The purpose of this project is to explore the knowledge, attitudes, subjective norms
and prescribing intentions among Tennessee NPs in response to the Naloxone Rescue Act. The
investigator will attempt to answer the following three project questions: 1) Does lack of
knowledge of naloxone distribution laws correlate with NPs’ intentions to prescribe naloxone to
laypersons? 2) Do underlying attitudes or subjective norms correlate with NPs’ intentions to
prescribe naloxone to laypersons? 3) Do correlations exist between NPs practicing in certain
geographical practice locations (i.e. rural, urban, or combined) and intention to prescribe
naloxone?
Theoretical Framework
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To better capture the philosophical underpinnings of this project, a theoretical framework
was used throughout its design. Social psychologists Ajzen and Fishbein (1980) first developed
philosophies on the relationship between an individual’s attitudes and his or her behavior. Their
book introduced the theory of reasoned action (TRA) into a broad range of professions and
explained the association between attitudes, beliefs, intentions, and behavior (Kuhns & McEwen,
2011). The TRA’s goal was to better understand a variety of positive and negative behaviors and
to predict individuals’ choices to perform these behaviors (Glanz, Burke, & Rimer, 2015).
The following concepts were explored in the TRA conceptual model: behavioral beliefs,
evaluations of behavioral outcomes, attitude toward behavior, normative beliefs, motivation to
comply, subjective norm, behavioral intention and behavior (Ajzen & Fishbein, 1980).
According to the TRA’s definitions, behavioral belief involved the view that certain attributes
are associated with behavioral performance (Evans, Ndetan, & Williams, 2009). The evaluation
of behavioral outcomes could be of positive or negative value, and the attitude toward behavior
referred to the individual’s overall acceptability of the performed behavior (Kuhns & McEwen,
2011). Normative beliefs, also known as subjective norms, reflected the social pressure on an
individual to engage or disengage in a particular behavior (Kuhns & McEwen, 2011). Similar to
normative beliefs, motivation to comply involved the subjective motivation of an individual to
act according to the expectation of others (Evans et al., 2009). Glanz et al. (2015) stated that
behavior intention, which is the individual’s perceived probability to perform the behavior, is the
most significant predictor of behavior.
According to Kuhns and McEwen (2011), the TRA made the assumption that people are
capable of making rational decisions based on what information they have received. Therefore, it
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may also be assumed that the TRA interprets voluntary behavior rather than involuntary action.
In addition, the TRA assumed that intention is the primary determinant of individuals’ behaviors,
and the other factors may be weighted differently from person to person (Glanz et al., 2015).
Glanz et al. (2015) described how the TRA conceptual relationships create a formula for
self-efficacy and a catalyst for behavior change potential.
Application of a Modified Theory of Reasoned Action
With its psychosocial roots, the TRA was a natural fit for a project examining attitudes
and beliefs of NPs and their intentions to prescribe naloxone for layperson use in Tennessee.
Some NPs may have underlying normative beliefs regarding opioid abusers or overdose events,
which may influence their intentions to prescribe naloxone. Their innate attitudes about naloxone
access to the public may also weigh their decisions to prescribe in certain practice settings. They
may fear liability or legal repercussions if they prescribe naloxone. In some clinics, providers
may feel a need to conform to behaviors based on other providers’ support or opposition to the
new laws.
Though the TRA will provide useful insight into the underlying attitudes, beliefs, and
intentions of NPs, the investigator also identified knowledge as a likely influencing factor for
behavior change. Because Tennessee’s Naloxone Rescue Act has only recently been introduced
to providers, many NPs may lack knowledge of its existence or the availability of naloxone for
public use. This lack of awareness may directly correlate with their prescribing beliefs,
evaluations of prescribing outcomes, and attitudes toward prescribing naloxone. Knowledge was
not directly explored as a variable in the TRA, but Bandura’s (1994) social cognitive learning
theory linked knowledge with self-efficacy as a strong indicator that a person will feel confident
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enough to perform specific tasks. Stanley and Pollard (2013) combined knowledge and
self-efficacy with underlying attitudes in their study examining nurse management of pediatric
pain. After considering the purpose of this scholarly project, the TRA combined with the
knowledge variable of the social cognitive learning theory provided the most comprehensive
approach to determining the factors influencing provider intention to prescribe. Figure 1 provides
a conceptual model for the modified TRA.
Methods
Participants
In Tennessee, advanced practice registered nurses (APRNs) made up 35 of the top 50
opioid prescribers (Tennessee Nurses Association, 2014). Therefore, NPs were chosen as a
representative provider sample who regularly treat and prescribe to patients at-risk for opioid
overdose. A public record list of 10,910 Tennessee APRNs was obtained on March 27, 2015, via
the TDH’s (2015a) health professional licensing public report database. Using purposive
sampling, this list was screened to remove duplicates and APRNs with no listed email address.
After excluding all APRNs other than NPs, 6,196 NPs (N=
 6,196) were solicited to be potential
study participants. The following inclusion criteria were applied to NP survey responses in order
to retain the final sample: must prescribe opioids to patients in practice, must practice in
Tennessee, must work in primary care clinic, family practice, pain management practice, or
emergency department (ED). Nurse practitioners receiving the survey were also required to have
a working email and internet connection to access the survey’s uniform resource locator (URL).
Materials
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Data collection tool. The Take-Home Naloxone Prescriber survey (THNPS) was used to
gather data for this project. The investigator used the modified TRA as a theoretical framework
to develop survey questions. Though a standardized data collection tool was desired, the
investigator was unable to identify one that met the needs of this study. In addition, a study by
Darker and French (2009) demonstrated that study participants could not adequately comprehend
overly standardized theory-based questionnaires or lengthy surveys. With this in mind, the
investigator was able to use necessary flexibility with the modified TRA survey. This flexibility
helped the investigator explore the pertinent constructs and cater the survey to the selected
audience.
Designed for healthcare providers with a masters-level degree, the THNPS asked 15
close-ended questions to reflect to the main concepts of the modified TRA: knowledge, attitudes,
subjective norms, and intentions. Underneath each of these headings, specific questions were
asked that addressed the concept in relation to NP prescribing practices. All THNPS questions
were quantitative in nature with one qualitative free-text section included at the end of the survey
for participants to include additional comments as needed. Questions were formatted in the
English language, and the following terms were defined: prescription opioids, heroin, take-home
naloxone, laypersons, and protocols. Five demographic (gender, race/ethnicity), geographic
(urban versus rural counties), and practice-specific (years of working experience, current
employment specialty) questions were included to further screen participants and establish
variable relationships. Though the THNPS has not gone through standard methods for validation,
the data collection tool was externally reviewed and approved by three experts for content
validity (Huck, 2012b). The THNPS was also tested among a sample group of 21 individuals to
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determine internal consistency. The THNPS survey instrument is displayed in Table 1 and
demographic items are located in Table 2.
Apparatus. Qualtrics web-based survey software was used to design and distribute the
THNPS via email. A Microsoft Excel list of 6,196 NPs was imported into Qualtrics with first
name, last name, and email address. The investigator programmed survey software to allow
participation by invitation only and prevent participants from completing more than one survey.
The software was also programmed to distribute emails to participants and to anonymize
participants’ responses, which alphanumerically coded responses and removed identifying
information. Responses were programmed to be saved but not recorded until participants
submitted their completed surveys. Prior to being exported for statistical analyses, responses
were stored as raw data in Qualtrics’ secured, on-line database. Per the software’s security
statement, all data collected, transferred, or stored via the Qualtrics (2015) survey were protected
by high-end firewall systems. Transport Layer Security (TLS) encryption and password
protection were used to store data according to Health Information Technology for Economic
and Clinical Health Act (HITECH) requirements (Qualtrics, 2015). Only the investigator had
access to the password and collected data. The Statistical Package for the Social Sciences (SPSS)
software was used for statistical analyses.
Monetary incentive. A $150 Visa pre-paid gift card was promoted as a monetary
incentive in the survey invitation email to boost response rates. Although all responses were
anonymized and coded, the investigator was able to use Qualtrics software to randomly select the
$150 Visa pre-paid gift card winner upon survey completion. The original NP sample was linked
to the THNPS for scheduled email distribution. Using Qualtrics’ programmable filters, the
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investigator extracted qualified participants into a separate sample by tracking THNPS email
distribution and survey completion history. Therefore, 977 NPs who completed the survey were
identified without linking participants to their responses. Using Qualtrics’ randomization feature,
this sample was randomized 20 times prior to selecting the 57th name on the list as the winner.
The number 57 was chosen using the Random Number Generator (2015) site. The winner was
sent a congratulatory email through the Qualtrics website and asked to confirm his or her mailing
address. The winner received the Visa gift card via U.S. Postal Service.
Design
A descriptive and correlational design was used for this project. To achieve the project’s
purpose, the investigator sought to explain relationships among the independent and dependent
variables. Intention to prescribe was established as the dependent variable. Knowledge, attitudes,
subjective norms, and geographic location were deemed independent variables.
Procedures
Data collection. Data collection took place from October 7, 2015 to November 7, 2015.
Survey invitation emails with the project explanation and THNPS URL were scheduled for
distribution at 0700 on October 7th. Invitation emails explicitly stated that participation was
voluntary and clicking on the survey URL implied consent to the study. Reminder emails were
scheduled at weekly intervals and were sent only to NPs who had not completed the survey. In
order to boost response rates, emails advertised a $150 Visa pre-paid gift card to one randomly
selected participant who completed the survey. On average, participants completed the survey in
approximately seven minutes, and completed survey responses were automatically recorded
upon submission. When participants submitted their surveys, they received a thank you email,
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which further described Tennessee’ Naloxone Rescue Act and provided a link to the TDH
naloxone information site. Invitation and reminder emails included an option to opt out of the
study, and clicking on the “unsubscribe” link removed participants from the email list and
sample. The investigator’s contact details were also provided in each email, so participants could
ask questions or voice concerns.
Statistical analyses. Survey responses were exported as raw data from the Qualtrics
database into SPSS for statistical analyses. Questions and responses were coded
alphanumerically and analyzed in SPSS. Intention to prescribe was deemed the dependent
variable, and all other question responses were considered independent variables. Descriptive
statistics were used to determine participants’ demographic characteristics, and demographic
characteristics were correlated with intention to prescribe using Pearson’s Chi-Square statistical
tests. Chi-Square statistical tests were also used to determine correlations among participants’
responses regarding knowledge, attitudes, subjective norms, with intention to prescribe THN. To
avoid cell sizes too small to appropriately perform Chi-Square testing, the Likert scale responses
found in Table 1 of agree, strongly agree, and disagree, strongly disagree, were combined and
recoded to agree and disagree as seen in Table 3. For the same reason, responses for question 2
in Table 1 were combined and recoded to very aware, somewhat aware, and not aware.
Statistical significance was established at alpha level 0.05. When Chi-Square tests generated
statistically significant results (i.e. p<
 0.05), post hoc procedures were used to identify more
specific correlations and better answer research questions as suggested by Huck (2012a) and
Sheskin (2004). While several acceptable approaches have been used for post hoc testing of
Chi-Square results, the investigator employed the standardized residual method for post hoc
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testing in this study (Garcia-Perez & Nunez-Anton, 2003; Sheskin, 2004; Beasley &
Schumacker, 1995; how2stats, 2014).
Ethics statement. This project was approved by the Institutional Review Board of
Belmont University in Nashville, Tennessee.
Results
Sample Characteristics
Out of 6,196 NPs (N=6,196) solicited, 2,652 NPs opened the invitation email, and 1,149
started the survey. Of the participants who started the survey, 977 completed the entire survey,
which elicited a response rate of 15.8%. After applying inclusion criteria to completed responses,
343 NPs (n=343) were kept as the final participant sample. Because most of the final sample
were white (n=312 [91%]) and female (n=310 [90.4%]), demographic data were compared with
all Tennessee APRN demographic statistics to determine if this homogeneity was proportionally
similar to statewide APRN demographics. This comparison showed that overall Tennessee
APRN demographics also reflect 90.2% female and 81% white characteristics, which
demonstrates that the study’s sample is representative of Tennessee’s APRN population
(Tennessee Action Coalition, n. d.). Many NPs reported between 1 to 6 years of experience
(n=154 [44.9%]), employment in family practice site (n=
 170 [49.6%]), and practice locations in
urban areas (n=
 172 [50.1%]). See Table 2 for further details on sample characteristics.
Sample characteristics and intention to prescribe. When correlating the samples’
characteristics with intention to prescribe, practice site was the only variable that significantly
correlated with intention to prescribe (p=0.000). According to post hoc tests, a strong, significant
correlation was found between NPs practicing in pain management clinics and intention to
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prescribe naloxone (p<
 0.001). In contrast, NPs practicing at family practice sites reported no
intention to prescribe naloxone, which was statistically significant at p<
 0.05. No significant
correlation was found between intention to prescribe and gender, race/ethnicity, years of
experience, and urban or rural location. See Table 2 for the samples’ statistical characteristics in
correlation with intention to prescribe.
Intention to Prescribe Naloxone
From the sample of 343 NPs, only 16.6% (n=57) reported that they intend to prescribe
naloxone to laypersons. Of particular interest, this percentage increased to 58% (n=199) when
NPs were asked about their intentions to prescribe naloxone if protocols and prescribing
guidelines were in place. Overall, NPs predominantly reported being unsure (n=
 166 [48.4%])
about whether or not they intend to prescribe naloxone. Table 3 shows more details on NPs
responses regarding intention to prescribe. When instructed to select all that apply, most NPs
reported comfort in prescribing naloxone to the following individuals: patients taking moderate
to high doses of oral opioids for pain management (n=
 183), law enforcement personnel (n=
 167),
known or suspected oral opioid addicts (n=136), and family members or friends of patients
taking oral opioids for pain management (n=124). Figure 1 displays more information on to
whom NPs intend to prescribe naloxone.
Knowledge and intention to prescribe. Each of the three questions measuring NP
knowledge of THN and their relationships to NP intention to prescribe THN indicated strong
statistical significance (p=
 0.000). When asked about their knowledge of THN distribution
initiatives in the U.S., 46.1% (n=158) of NPs reported that they were very aware. Of the NPs
who were very aware of THN distribution, most (44.3% [n=
 70]) were unsure if they would
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prescribe naloxone. A significant correlation was seen between NPs who were not aware of THN
distribution and who did not intend to prescribe THN (p<
 0.001). In regard to knowledge about
Tennessee’s THN laws, 62.1% (n=
 213) of NPs said they were unsure, 19% (n=65) said they
were aware, and 19% (n=
 65) said they were unaware of these laws. Those who were aware of
Tennessee’s THN laws were also more likely to prescribe naloxone (p<0.001). Furthermore, NPs
who were unaware of Tennessee’s laws reported that they do not intend to prescribe naloxone
(p<0.01). Only 5% (n=17) of the sample had previously prescribed THN in their practice, and
the remaining 95% (n=326) reported no experience prescribing THN. In a strong correlation, the
NPs who previously prescribed THN were significantly more likely to prescribe THN in the
future (n=
 16 [94.1%], p<
 0.001). There were also significant correlations between those who had
never prescribed THN and NPs who do not intend to prescribe (p<
 0.01) and those who were
unsure if they would prescribe (p<
 0.001). See Table 3 for further details on how NP knowledge
correlated with intention to prescribe naloxone.
Attitudes and intention to prescribe. When measuring each of the four questions
correlating NP attitudes about THN and intention to prescribe THN, strong statistical
significance was found (p=0.000). Forty-eight percent (n= 166) of NPs felt that THN is a good
strategy for opioid prevention, but they predominantly remained unsure regarding intention to
prescribe THN (p<
 0.01). Nurse practitioners who disagreed that THN is a good strategy were
significantly opposed to prescribing THN (p<0.001). Seventy percent (n= 240) of NPs agreed
that laypersons can safely and effectively administer THN in overdose events; however, these
NPs mostly reported being unsure whether or not they intend to prescribe THN (p<0.001). Those
who disagreed with the safety and effectiveness of layperson administration were significantly
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less likely to prescribe THN (p<
 0.001). In regard to legal implications, most NPs (n=
 157
[45.8%] and n=157 [45.8%]) neither agreed nor disagreed that they felt protected by criminal or
civil prosecution if they prescribed THN to laypersons. A very small portion of NPs (n=66
[19.2%] and n=54 [15.7%]) did feel protected from criminal and civil prosecution, which
correlated significantly with intention to prescribe THN (p<
 0.001 and p<
 0.001). Additional
statistical correlations between attitudes and intention to prescribe may be found in Table 3.
Subjective norms and intention to prescribe. Three out of the four questions covering
subjective norms significantly correlated with intention to prescribe. Most NPs (n=
 152 [44.3%])
reported that their health provider peers were unaware of THN laws, which significantly
correlated with deciding not to prescribe THN (p<
 0.05). When asked if their health provider
peers supported THN prescription, NPs predominantly responded neither agree nor disagree
(n=202 [58.95]), which directly related with being unsure of intention to prescribe (p<
 0.001).
Even though most NPs were ambivalent, those who felt their provider peers supported THN
were more likely to prescribe THN themselves (p<
 0.001), and those who felt their provider peers
opposed THN were less likely to prescribe THN themselves (p<
 0.001). Regardless, NPs reported
that peer pressure was not an influencing subjective norm (n=
 244 [71.1%]) and was not
significantly related to intention to prescribe (p=
 0.447). Most NPs (n=1 84 [53.6%]) disagreed
that personal reasons would influence their decision to prescribe THN, which significantly
correlated with their report that they do not intend to prescribe THN to laypersons (p<
 0.01).
Table 3 displays correlations between subjective norms and intention to prescribe in further
detail.
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Discussion
Geographic Location and Clinical Sites
At the beginning of this project, the investigator sought to establish if geographic location
(i.e. rural, urban, combined rural/urban) impacted NPs’ intentions to prescribe THN. It was
important to examine geographic implications as the literature suggests opioid overdose deaths
are more prevalent in rural areas (CDC, 2015b; Rosenblatt, Andrilla, Catlin, & Larson, 2015).
Also, evidence has yet to conclude whether or not prescribers’ attitudes and intentions to
distribute THN vary depending on if they practice in rural or urban locations. According to this
project’s findings, significant correlations were not found between NPs who practiced in rural,
urban, or combined areas and intention to prescribe. These findings suggest that geographical
locations do not seem to encourage nor deter NPs’ decisions to prescribe THN to laypersons. For
future rural opioid prevention outreach, Tennessee advocates may consider following the Project
Lazarus model, an OEP and naloxone distribution program that has dramatically decreased
overdose deaths in rural North Carolina (Albert et al., 2011).
While geographical locations of NPs were insignificant to their prescribing intentions,
the types of NP clinical practice sites were strongly significant. In particular, NPs practicing in
pain management clinics were significantly more likely to prescribe THN to laypersons. This
finding is important because NPs practicing in pain management clinics will have the greatest
access to patients taking large amounts of opioid pain medication who may be at risk for
overdose. Not only would these NPs have the opportunity to prescribe THN to patients along
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with their opioids, but they could also contribute valuable data regarding appropriate THN
candidate selection and actual THN use among oral opioid users. In contrast to pain management
NPs, family practice NPs were found to be significantly less likely to prescribe THN. Providing
insight into this finding, one study participant commented at the end of the survey, “I am wary of
prescribing narcotic pain medications in my practice, and I would refer patients needing
long-term treatment to pain management. They could then decide to prescribe naloxone.” The
sentiment that NPs would feel more comfortable deferring THN prescriptions to pain
management specialists was echoed in the literature and throughout the final comments section
by other family, adult primary care, and ED NPs (Matheson et al., 2014). In contrast, Leece,
Orkin, Shahin, and Steele (2015) and Klimas, Egan, Tobin, Coleman, and Bury (2015) found that
family practice providers in Canada and Ireland were not opposed to providing THN prescription
and overdose education in the primary care setting, and they did not suggest that specialist
involvement be required. It was interesting that only 7.5% of ED NPs in this study endorsed
intention to prescribe THN, since EDs have become a successful target location for naloxone
distribution efforts in other states (Dwyer et al., 2015; Samuels, 2014). The theory has been that
ED providers encounter the highest risk patients (i.e. individuals brought to the ED for opioid
overdose) and would be able to give them THN to prevent future overdose events (Dwyer et al.,
2015). This project’s findings suggested that ED naloxone distribution is not likely occurring in
Tennessee.
Knowledge
Over the last decade, THN distribution has been a popular topic among U.S.
policymakers, physicians, and public health professionals. With the recent increase in media
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coverage of the THN movement and expansion of legal accessibility to THN, it is not surprising
that many participants were aware of THN distribution across the U.S. as an opioid overdose
death prevention strategy. Despite being aware of the overall THN movement, only 19% of NPs
reported awareness of Tennessee’s law allowing THN prescription to laypersons. Of interest,
NPs with little to no knowledge of THN distribution in the U.S. or Tennessee were significantly
less likely to prescribe THN to laypersons, an association also found in other research studies
(Beletsky et al., 2007; Green et al., 2013). Sixteen of the seventeen NPs (94.1%) who had
previous experience prescribing THN to laypersons responded “yes” when asked if they intend
to prescribe THN to laypersons in the future, which demonstrates how adequate knowledge
positively influences intention to prescribe. These correlational findings between knowledge and
intention to prescribe make sense, as NPs are educated to prescribe medications of which they
have a sufficient understanding and familiarity.
Demonstrating the disconnect between general awareness and prescriptive competency,
Wilson, Spicyn, Matson, Alvanzo, and Feldman (2016) found that 80% of internal medicine
residents were aware of THN use with 90% reportedly willing to prescribe THN to laypersons,
yet only 15% applied the knowledge by prescribing THN to at-risk patients. Researchers and
policymakers are calling for improved provider-focused education so that prescribers are aware
of THN’s evidence-based safety and efficacy, know how to appropriately prescribe THN, and
understand the legal implications of prescribing THN to laypersons (Beletsky et al., 2007; Green
et al., 2013; Kim et al., 2009; Klimas et al., 2015; Leece et al., 2015; Wilson et al., 2016).
Attitudes
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Along with knowledge, this project established a significant correlation between NP
attitudes toward prescribing THN and willingness to prescribe THN to patients and their families
or friends. While NP responses portrayed predominantly positive attitudes toward the THN
distribution movement and laypersons’ capabilities to safely and successfully administer THN to
overdose victims, most remained undecided on their intentions to prescribe THN. These findings
suggested that positive attitudes do not necessarily predict that NPs will prescribe THN in their
practices, which paralleled the findings of other studies (Leece et al., 2015; Wilson et al., 2016).
This study also demonstrated that negative attitudes toward THN correlate significantly with
unwillingness to prescribe THN to laypersons.
In the survey’s comment section, NPs expressed concern that opioid abusers would feel
false security if prescribed THN and subsequently engage in riskier opioid use. Throughout the
literature, this THN safety net fear has contributed to negative attitudes among healthcare
providers, law enforcement, paramedics, and the general public (Banta-Green, Beletsky,
Schoeppe, Coffin, & Kuszler, 2013; Beletsky et al., 2007; Green et al., 2013; Kim et al., 2009;
Leece et al., 2015). Despite this concern, evidence has consistently shown that laypersons do not
participate in increased or riskier opioid use when given THN, and experts have explained that
opioid-dependent persons typically avoid naloxone’s intensely unpleasant yet harmless opioid
withdrawal symptoms (Kim et al., 2009). Other NPs voiced concern over risks of adverse
reactions, such as seizures, arrhythmias, pulmonary edema, and the return of respiratory
depression due to naloxone’s short half-life. However, a thorough literature review of naloxone’s
pharmacological safety and efficacy concluded that serious adverse effects were rare and often
caused by comorbidities, polysubstance use, or prolonged hypoxia, rather than the naloxone
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itself (Wermeling, 2015). Evidence also suggested that repeat dosing of IN and injectable THN
for recurring respiratory depression in pre-hospital overdose events was rare and more often
occurred during inpatient IV naloxone reversals due to IV naloxone’s faster pharmacokinetics
(Wermeling, 2015).
Attitudes toward medicolegal implications also significantly correlated with NPs’
intentions to prescribe THN. When assessing NPs’ attitudes toward the medicolegal implications
of writing THN prescriptions, overall responses were negative. Only 19.2% felt they were
protected from criminal prosecution, while even less (15.7%) believed they were immune from
civil liability if they prescribed THN to laypersons. Though these percentages of NPs were small,
findings show that NPs with full understanding and confidence in their state’s naloxone
legislation demonstrate more willingness to prescribe THN to laypersons. Most NPs neither
agreed nor disagreed when asked if they felt legally protected to prescribe THN, which suggests
that providers may be confused by, unaware of, or ambivalent toward naloxone laws. While
many states, including Tennessee, have expanded legislation to ensure better provider protection,
these findings add to evidence claiming that healthcare providers still feel that prescribing THN
to laypersons could result in legal repercussions (Beletsky et al., 2007; Green et al., 2013; Leece
et al., 2015). For example, one of the NPs practicing in a pain management clinic commented
that although she felt prescribing THN was a good idea, she was afraid that writing THN
prescriptions for her patients would send the message that she is prescribing inappropriate
amounts of opioids. While perceptions of malpractice liability remain a barrier to providers
prescribing THN, the true legal risk to providers has been low (Burris et al., 2009). Ultimately,
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NPs and other providers will need clarification on medicolegal truths surrounding THN
prescription.

Subjective Norms
Adding to this project’s findings on knowledge and attitudes, subjective norms were
significantly associated with NPs intentions to prescribe THN. Healthcare providers’ reluctance
to prescribe THN has often been attributed to lack of support from other providers and the
medical community (Beletsky et al., 2007; Leece et al., 2015). However, this study found 71.1%
of NPs indicated that peer pressure from other providers would not influence whether or not they
decide to prescribe THN, and peer pressure was the only subjective norm that showed no
significant correlation with prescribing intention. This finding could be because most NPs also
believed that their provider peers were unaware of THN distribution, and they were uncertain of
peer providers’ support for THN distribution. The stigma surrounding opioid abusers and addicts
has also been a widely recognized barrier to provider prescription of THN, as providers may fear
professional or social criticism when writing THN prescriptions for this population (Beletsky et
al., 2007; Green at al., 2013; Leece et al., 2015). By introducing accurate and evidence-based
information to providers and the general public, this stigma could be reversed.
Intention to Prescribe, Prescribing Protocols and Appropriate Naloxone Recipients
A mere 16.6% of NPs in this project intended to prescribe THN to laypersons, which was
a much smaller percentage than the 46% of physicians polled in a study by Beletsky et al.
(2007). This discrepancy may be attributable to the fact that this project’s sample had a much
smaller percentage (16.3%) of NPs treating patients for pain management. Regardless, NPs’
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responses revealed a dramatic positive shift to 58% when asked if they would prescribe THN
with prescribing protocols in place. This finding provides quantifiable support for the consistent
recommendation that prescribing protocols and standard guidelines would increase healthcare
providers’ prescribing practices (Green et al., 2013; Leece et al., 2015; Wermeling, 2015; Wilson
et al., 2016). Protocols would ensure that providers uniformly write prescriptions in an
evidence-based manner, which could reduce ambiguity and make providers feel more secure.
Developed by an advocacy group of public health experts, physicians, pharmacists, and
attorneys, prescribetoprevent.org provides current naloxone research, legal facts, and prescribing
guidelines to healthcare providers so that they may make informed decisions when considering
THN prescription (Prescribe to Prevent, 2015). Many NPs participating in this project expressed
their desire for evidence, training, and prescribing guidelines to clarify confusion and enhance
their confidence when prescribing THN.
For providers who intend to prescribe THN, astute identification of THN candidates
should be a priority. While this priority has been thoroughly discussed throughout the literature,
there has been much debate over what defines a patient as “high-risk” and whether third-party
prescription is appropriate (Beletsky et al., 2007; Green et al., 2013; Leece et al., 2015). In this
project, NPs selected the following as the four most appropriate candidates for THN prescription:
patients prescribed moderate to high doses of opioids for pain management, law enforcement,
individuals addicted to oral opioids, and family and friends of patients taking prescribed opioids.
Nurse practitioners’ candidate selections provided support for current efforts to dispense THN to
individuals who would be the first to arrive at overdose events, such as police officers
(Banta-Green et al., 2013). This project’s findings showed more support for THN prescription to
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oral opioid users and their associates, which is significant because research has instead focused
on THN distribution to IV drug users (Wheeler et al., 2015). To help providers identify
appropriate THN candidates, Prescribe to Prevent (2015) offers standardized screening tools on
its website.
Limitations
While this project produced significant findings, certain limitations must be considered.
The investigator created the THNPS based on theoretical underpinnings and pertinent literature
findings; however, the survey has not yet been formally validated. A validated survey instrument
would have added further rigor to this study’s findings. In addition, the survey included a
comments section in which NPs could provide additional thoughts and feelings if they so chose.
It may have been useful to provide further opportunities for open-ended commentary with each
quantitative question to better capture NPs’ knowledge, attitudes, subjective norms, and
intentions. Furthermore, only family practice, adult primary, ED, and pain management NPs
were included in the final sample. In hindsight, it may have been valuable to include the
responses of all NPs, especially those practicing in mental health or substance abuse specialties
because they regularly encounter patients with opioid abuse disorders.
Lastly, the time period for data collection coincided with the CVS (2015) announcement
that THN would be provided without individual prescription in Tennessee along with 12 other
states. While this timing could not be helped, it is possible that NPs’ responses were impacted by
the media coverage. Ultimately, THN distribution is an evolving movement with current efforts
striving for pharmacy-dispensing models and over-the-counter availability. Both aforementioned
strategies would reduce the urgency for provider prescription; however, it will always be
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imperative for healthcare providers to be knowledgeable about THN, provide sufficient
education for patients, and direct appropriate candidates to places where they can obtain THN.
Furthermore, healthcare providers will likely still be needed for THN prescriptions to combat
rising costs of naloxone and uncertain insurance coverage (Thompson, 2015). Regardless, some
states still have not introduced or fully adopted strategies in which individuals can acquire THN
without prescription, so healthcare providers currently remain the necessary link to THN access.
Recommendations
From this project’s findings, the investigator proposes specific recommendations for
future research and NP practice. Nurse practitioners and other healthcare providers must be
educated on the evidence surrounding THN safety and efficacy. Without knowledge of THN’s
effectiveness in reducing opioid overdose deaths, NPs are less likely to prescribe it to their
patients. Furthermore, THN advocates should increase specific messaging to healthcare
providers and promote incentives for prescribing THN to change attitudes toward THN
distribution. Medicolegal truths should be explained to NPs to increase confidence in their
protection from malpractice liability when prescribing THN. Better education and training
should be implemented among the entire medical community to deliver a clear and factual
message regarding THN distribution to candidates so that providers will feel better support for
prescribing THN. Nurse practitioners should be involved with developing and implementing
THN prescribing protocols, identifying appropriate candidates, facilitating community outreach
efforts, and initiating new research on THN’s effectiveness in practice. More data are needed to
best execute THN distribution to oral opioid abusers or patients taking high doses of opioids for
pain management. Therefore, NPs practicing in pain management specialties may be able to
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provide this information. Ultimately, efforts should be made to incorporate THN distribution
with other strategies to decrease opioid abuse, diversion, and overdose. More research is needed
on THN effectiveness among individuals taking prescribed opioids for pain management.

Conclusion
While many factors contribute to NPs’ lack of involvement with THN distribution,
knowledge, attitudes, and subjective norms remain influencing factors for intention to prescribe.
This DNP project’s findings add breadth to the existing literature along with new information on
NPs’ perceptions and willingness to prescribe. Better education, training, legal guidance, and
support should be given to NPs to increase their confidence in THN prescription and distribution.
Prescribing protocols should be developed to ensure safe and efficient THN prescription by NPs.
To address this growing opioid overdose epidemic in Tennessee and across the U.S., it is
imperative that NPs and other healthcare providers take this opportunity to advocate for patients
at risk for opioid overdose, implement preventative efforts through safer opioid prescribing
practices, and prescribe THN to appropriate persons to help save lives.
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Appendix
Table 1
Take-Home Naloxone Provider Survey (THNPS) Questions and Answers
TRA
Concept
Knowledge

THNPS Question
1) Do you prescribe opioid pain medication in your
current practice?

Answer Choices
Yes
No

2) Which answer best describes your knowledge about
the following statements?

I have NEVER
heard of this

In many states, healthcare providers may legally
prescribe take-home naloxone to non-medically trained
laypersons. After being trained on how to recognize
signs of overdose and administer naloxone, these
laypersons may legally administer naloxone to opioid
overdose victims in a non-hospital setting.

I have heard of
this, but I am NOT
SURE what it
means
I have heard of
this, and I am
SOMEWHAT
SURE what it
means
I have heard of
this, and I am
VERY SURE what
it means.

3) Does Tennessee have a law that permits healthcare
provider prescription of naloxone to laypersons for
emergency use in non-hospital overdose events?

Yes
No
Unsure
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Attitudes

4) Have you ever prescribed naloxone for a layperson to
administer to opioid overdose victims in non-hospital
settings?

Yes

5) Select the answer that best describes your feelings
toward the following statement.

Strongly disagree

No

Disagree
Prescribing take-home naloxone to laypersons is a good
strategy for overdose death prevention.

Neither agree nor
disagree
Agree
Strongly agree

6) Select the answer that best describes your feelings
toward the following statement.

Strongly disagree
Disagree

Laypersons receiving appropriate overdose response
training can safely and successfully administer
naloxone to overdose victims in non-hospital settings.

Neither agree nor
disagree
Agree
Strongly agree

7) Select the answer that best describes your feelings
toward the following statement.

Strongly disagree
Disagree

I am protected from criminal prosecution if I prescribe
take-home naloxone to patients at my practice site.

Neither agree nor
disagree
Agree
Strongly agree

8) Select the answer that best describes your feelings
toward the following statement.

Strongly disagree
Disagree

I am protected from civil liability if I prescribe
take-home naloxone to patients at my practice site.

Neither agree nor
disagree
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Agree
Strongly agree
Subjective
Norms

9) Select the answer that best describes your feelings
toward the following statement.

Strongly disagree
Disagree

Providers in my current practice site are aware of
naloxone prescription to laypersons.

Neither agree nor
disagree
Agree
Strongly agree

10) Select the answer that best describes your feelings
toward the following statement.

Strongly disagree
Disagree

Providers in my current practice site support naloxone
prescription to laypersons.

Neither agree nor
disagree
Agree
Strongly agree

11) Select the answer that best describes your feelings
toward the following statement.

Strongly disagree
Disagree

Peer pressure from other prescribers at my practice site
will influence my decision to prescribe or not prescribe
take-home naloxone to laypersons.

Neither agree nor
disagree
Agree
Strongly agree

12) Select the answer that best describes your feelings
toward the following statement.

Strongly disagree
Disagree

I have personal reasons that motivate my decision to
prescribe take-home naloxone to laypersons.
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Neither agree nor
disagree
Agree
Strongly agree
Intentions

13) Do you intend to prescribe naloxone to laypersons
for use in non-hospital emergency overdose events?

Yes
No
Unsure

14) If your practice site had a protocol to help guide
provider prescription of take-home naloxone, would
you prescribe naloxone to laypersons for use in
non-hospital emergency overdose events?

Yes
No
Unsure

15) Select all answers that apply (You may choose
multiple answers).
In your current practice, which individuals would you
feel comfortable prescribing naloxone to?

Patients taking low
to moderate doses
of opioid pain
medication for pain
management
Patients taking
moderate to high
doses of opioid
pain medication for
pain management
Known or
suspected oral
opioid addicts
Known or
suspected heroin
addicts
Family members or
friends of patients
taking opioid pain
medication
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Family members or
friends of IV
heroin and oral
opioid abusers
Law enforcement
personnel
Any individual
who requests
naloxone
prescription and
training
None

Note. TRA modified to include the concept of knowledge for this study

Other (please
specify)
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Table 2
Demographic Characteristics of Participants
Demographic

Total
n=343
(100%)

Intend to Prescribe Naloxone
Yes
No
Unsure
n=57
n=120
n=166
(16.6%)
(35.0%)
(48.4%)

Gender

p
0.456

Male
Female
Race/Ethnicity
White
Black/African American
Hispanic/Latino
Asian
American Indian/Alaskan
Native
Native Hawaiian/Other
Pacific Islander
Two or more races
Declined to answer
NP Years of Experience
Less than 1
1 to 2
3 to 4
5 to 6
7 to 8
9 to 10
11 to 12
13 to 14

33 (9.6)
310
(90.4)

8 (24.2)
49 (15.8)

10 (30.3)
110 (35.5)

15 (45.5)
151 (48.7)

312
(91.0)
19 (5.5)
4 (1.2)
1 (0.3)
1 (0.3)

51 (16.3)

111 (35.6)

150 (48.1)

5 (26.3)
0 (0.0)
0 (0.0)
0 (0.0)

6 (31.6)
1 (25.0)
0 (0.0)
0 (0.0)

8 (42.1)
3 (75.0)
1 (100)
1 (100)

1 (0.3)

0 (0.0)

1 (100)

0 (0.0)

2 (0.6)
3 (0.9)

0 (0.0)
1 (33.3)

0 (0.0)
1 (33.3)

2 (100)
1 (33.3)

4 (1.2)
50
(14.6)
49
(14.3)
55
(16.0)
32 (9.3)
32 (9.3)
17 (5.0)
21 (6.1)

1 (25.0)
7 (14.0)

1 (25.0)
21 (42.0)

2 (50.0)
22 (44.0)

11 (22.5)

13 (26.5)

25 (51.0)

7 (12.7)

25 (45.5)

23 (41.8)

1 (3.1)
6 (18.7)
3 (17.7)
4 (19.1)

16 (50.0)
11 (34.4)
9 (52.9)
6 (28.6)

15 (46.9)
15 (46.9)
5 (29.4)
11 (52.4)

0.799

0.070
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15 to 16
17 to 18
19 to 20
More than 20
Practice Site
Adult primary care clinic
Family practice clinic
Pain management clinic
Emergency department
Practice Location
Rural
Urban
Combined rural and urban

20 (5.8)
18 (5.2)
11 (3.2)
34 (9.9)

4 (20.0)
5 (27.8)
0 (0.0)
8 (23.5)

8 (40.0)
0 (0.0)
4 (36.4)
6 (17.7)

8 (40.0)
13 (72.2)
11 (63.6)
20 (58.8)
0.000
*

77
(22.4)
170
(49.6)
56
(16.3)
40
(11.7)

10 (13.0)

26 (33.8)

41 (53.2)

69 (40.6)†

82 (48.2)

10 (17.9)φ

21 (37.5)

15 (37.5)

22 (55.0)

11 (13.6)

26 (32.1)

44 (54.3)

33 (19.2)

61 (35.5)

78 (45.3)

13 (14.4)

33 (36.7)

44 (48.9)

19
(11.2)φ
25
(44.6)*
3 (7.5)

0.629
81
(23.6)
172
(50.1)
90
(26.2)

Note. Rural and urban counties defined using the 2010 U.S. Census Office of Management and
Budget (OMB) map of Tennessee counties.
† = p < 0.05; φ = p < 0.01; * = p < 0.001
Table 3
Summary of Factors Influencing Nurse Practitioners’ Intentions to Prescribe Naloxone to
Laypersons
Influencing Factors
Aware of take-home naloxone
distribution in the U.S.
Very aware
Somewhat aware
Not aware
Knowledge of Tennessee’s
naloxone distribution law
Yes

Total
n=343
(100%)

Intend to Prescribe Naloxone
Yes
No
Unsure
n=57
n=120
n=166
(16.6%)
(35.0%)
(48.4%)

p
0.000
*

158
(46.1)
73
(21.3)
112
(32.6)

46
(29.1)*
7 (9.6)

65
(19.0)

25
(38.5)*

4 (3.6)*

42 (26.6)φ

70 (44.3)

24 (32.9)

42 (57.5)

54 (48.2)*

54 (48.2)
0.000
*

12 (18.5)φ

28 (43.1)
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No
Unsure
Previously prescribed take-home
naloxone to laypersons
Yes
No
Prescribing take-home naloxone is a
good overdose prevention strategy
Agree
Neither agree nor disagree
Disagree
Laypersons can safely and
successfully administer naloxone to
overdose victims
Agree
Neither agree nor disagree
Disagree
Feel protected from criminal
prosecution if prescribing
take-home naloxone
Agree
Neither agree nor disagree
Disagree
Feel protected from civil liability if
prescribing take-home naloxone
Agree
Neither agree nor disagree
Disagree
Health provider peers are aware of
take-home naloxone distribution

65
(19.0)
213
(62.1)

8 (12.3)
24
(11.3)*

33 (50.8)φ
75 (35.2)

24 (36.9)†
114 (53.5)†
0.000
*

17 (5.0)
326
(95.0)
166
(48.4)
102
(29.7)
75
(21.9)

16
(94.1)*
41
(12.6)*

0 (0.0)φ

1 (5.9)*

120 (36.8)φ

165 (50.6)*
0.000
*

50
(30.1)*
4 (3.9)*

21 (12.7)*

95 (57.2)φ

39 (38.2)

59 (57.8)†

3 (4.0)*

60 (80.0)*

12 (16.0)*
0.000
*

240
(70.0)
62
(18.1)
41
(12.0)

54
(22.5)*
2 (3.2)φ

51 (21.3)*

135 (56.3)*

36 (58.1)*

24 (38.7)

1 (2.4)φ

33 (80.5)*

66
(19.2)
157
(45.8)
120
(35.0)

29
(43.9)*
17
(10.8)φ
11 (9.2)φ

7 (17.1)*
0.000
*

13 (19.7)φ

24 (36.4)†

50 (31.8)

90 (57.3)φ

57 (47.5)*

52 (43.3)
0.000
*

54
(15.7)
157
(45.8)
132
(38.5)

9 (16.7)φ

24
(44.4)*
22 (14.0)

21 (38.9)

46 (29.3)†

89 (56.7)φ

11 (8.3)φ

65 (49.2)*

56 (42.4)
0.000
*
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Agree
Neither agree nor disagree
Disagree
Health provider peers support
take-home naloxone distribution
Agree
Neither agree nor disagree
Disagree
Peer pressure will influence
decision to prescribe or not
prescribe take-home naloxone
Agree
Neither agree nor disagree
Disagree
Have personal reasons that
influence decision to prescribe or
not prescribe take-home naloxone
Agree
Neither agree nor disagree
Disagree
Would prescribe take-home
naloxone if prescribing protocol
existed
Yes
No
Unsure

89
(25.9)
101
(29.4)
152
(44.3)

28
(31.5)*
14 (13.9)
14 (9.2)φ

27 (30.3)

34 (38.2)†

30 (29.7)

57 (56.4)

63 (41.4)†

75 (49.3)
0.000
*

49
(14.3)
202
(58.9)
91
(26.5)

31
(63.3)*
21
(10.4)*
4 (4.4)*

3 (6.1)*

15 (30.6)φ

59 (29.2)φ

122 (60.4)*

58 (63.7)*

29 (31.9)*
0.447

43
(12.5)
56
(16.3)
244
(71.1)

8 (18.6)

12 (27.9)

23 (53.5)

11 (19.6)

15 (26.8)

30 (53.6)

38 (15.6)

93 (38.1)

113 (46.3)
0.015
†

76
(22.2)
83
(24.2)
184
(53.6)

15 (19.7)

33 (43.4)

28 (36.8)†

7 (8.4)†

35 (42.2)

41 (49.4)

52 (28.3)φ

97 (52.7)

35 (19.0)

0.000
*
199
(58.0)
49
(14.3)
95
(27.7)

Note. † = p <
 0.05; φ = p < 0.01; * = p < 0.001

57
(28.6)*
0 (0.0)*

27 (13.6)*

115 (57.8)*

48 (98.0)*

1 (2.0)*

0 (0.0)*

45 (47.4)φ

50 (52.6)
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Modified Theory of Reasoned Action Conceptual Model

Figure 1
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Summary of Individuals to whom NPs Felt Comfortable Prescribing Take-Home Naloxone

Figure 2
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